Jared Brier, co-CEO and founder of AKKO joined Gilad Shai to discuss AKKO, Customer and User Experience, Warranty, and BMW Z4.
Gilad Shai and Yann Barbarroux, the CEO of Otonomi, talk about Otonomi and delayed cargo insurance.
Phil Friedman and Gilad Shai discuss iBynd and bouncing back after a major fall
Chang and Gilad discuss the Japanese venture ecosystem, surfing, and the role of CVCs in pushing VCs and entrepreneurs forward.
Patrick (Pat) Kelahan and Gilad Shai talk about the collapse of Champlain Towers South condominium in Surfside, Florida, and the insurance implications. They continue to talk about PropTech (Real-Estate Tech), the new and upcoming Blue Print conference, DailyFinTech, Pat's involvement with ventures around the globe, and the origin of the Insurance Elephant.
Andrew Johnston joins me from his new abode in Nashville, TN, to discuss InsurTech, investment, and shearing alpacas. Andrew's background is enthralling. He "sold" his Ph.d. to the UN, farmed sea cucumbers in Indonesia, and established Willis Re's InsurTech group.
..when is it [investments in InsurTech] going to burst? The answer is—it's really hard to know because if the terminology or the definition keeps getting wider and wider, then everything that is anything in our industry is going to be captured as an InsurTech investment.
In this episode, Dan White, managing partner at NINETY, and I talked about Dan’s “insurance bets” for 2021. Dan talked about Micro Insurance; lessons learned from microinsurance that carriers can implement in “medium insurance,” Intangible assets insurance, and ESG rating. We skipped Black Swan Re but did manage to learn about the Alchemy Crew.
“40 years ago, 83% of their (S&P 500) balance sheet would have been tangible assets. Today, it’s only 12%. “ John Neal, CEO Lloyd’s
Jay and I talked about the state of the workforce that makes the insurance industry, the challenges the legacy companies face to recruit employees to technology roles, and the impact of the COVID pandemic on the future of office-culture and performance.
To succeed, once they're (new talent) brought into to your organization, we work to prevent an organ rejection...
